2096 fundamentals
SIMCERE PHARMACEUTICAL GRP LTD financial statements, including revenue, expenses, and profit
The total revenue of 2096 for the last semiannual is 3.82 B HKD, and it's 13.23% higher compared to the previous semiannual. The net income of H2 24 is 300.02 M HKD.
Total revenue
Gross profit
Operating income
Pretax income
Net income
Currency: HKD
TTM